|
Quotes & Info
|
| DVAX > SEC Filings for DVAX > Form 8-K on 26-Feb-2013 | All Recent SEC Filings |
26-Feb-2013
Change in Directors or Principal Officers
(b) Departure of Directors or Certain Officers
On February 20, 2013, Christine R. Larson departed Dynavax as its Vice President and Chief Financial Officer, effective on February 28, 2013. Jennifer Lew, Dynavax's Vice President, Finance and Principal Accounting Officer, has assumed Ms. Larson's responsibilities.
|
|